Evidence map›Paper›PMID 41675640›Full record

ArticleFrontiers in endocrinology2025

Multi-gene co-mutations of

Qing Yu, Han Liu

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Qing YuDepartment of Pathology, Deyang People's Hospital, Deyang, China.
Han LiuDepartment of Pathology, Deyang People's Hospital, Deyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The accurate preoperative prediction of lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC) poses a significant clinical challenge. Although clinicopathological features are commonly utilized, their predictive accuracy remains limited, and the role of multi-gene co-mutations is not fully understood. Objective: This study aimed to develop and validate an integrated risk model that combines next-generation sequencing (NGS) data with clinicopathologic features for the preoperative prediction of LNM in PTC. Methods: We retrospectively analyzed 521 patients with PTC. Gene mutations were analyzed using NGS. Independent risk factors for central (CLNM) and lateral (LLNM) lymph node metastasis were identified through univariate and multivariate logistic regression analyses. Results: The Conclusion: Preoperative NGS profiling, particularly the detection of high-risk multi-gene co-mutations, provides a powerful tool for refined risk assessment. This molecularly guided strategy has the potential to inform personalized surgical planning directly, optimizing the extent of lymph node dissection to improve oncologic outcomes while minimizing unnecessary morbidity.

Indexed as

Biomarkers, TumorClass I Phosphatidylinositol 3-KinasesLymphatic MetastasisMutationProto-Oncogene Proteins B-rafTelomeraseThyroid Cancer, PapillaryThyroid NeoplasmsTumor Suppressor Protein p53AdultAgedFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedBiomarkers, TumorBRAF protein, humanClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanProto-Oncogene Proteins B-rafTelomeraseTERT protein, humanTP53 protein, humanTumor Suppressor Protein p53lymph node metastasismulti-gene co-mutationnext-generation sequencing (NGS)papillary thyroid carcinomarisk factors

Identifiers

PMID41675640
PMCPMC12886009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.